NEUROENDOCRINE BREAST TUMOUR

This adverse event was reported 18 times

These drugs are most commonly taken by patients reporting NEUROENDOCRINE BREAST TUMOUR:

# Drug Count
0 CAPECITABINE 4
1 LETROZOLE 4
2 LETROZOLE TABLETS 4
3 LEUPROLIDE ACETATE 4
4 PACLITAXEL 4
5 PACLITAXEL (AIBUMIN-BOUND) 4
6 PALBOCICLIB 4
7 ZOLEDRONIC ACID 4
8 ANASTROZOLE 1
9 ANASTROZOLE TABLETS 1
See all common drugs associated with NEUROENDOCRINE BREAST TUMOUR

NEUROENDOCRINE BREAST TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIPTORELIN PAMOATE 1 0.0004
1 ZOLEDRONIC ACID 4 0.0001
2 LETROZOLE TABLETS 4 0.0001
3 LETROZOLE 4 0.0001
4 LEUPROLIDE ACETATE 4 0.0001
5 ANASTROZOLE TABLETS 1 0.0000
6 CAPECITABINE 4 0.0000
7 PALBOCICLIB 4 0.0000
8 PACLITAXEL 4 0.0000
9 ANASTROZOLE 1 0.0000
See all drugs enriched for association with NEUROENDOCRINE BREAST TUMOUR

NEUROENDOCRINE BREAST TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aromatase Inhibitor [EPC] 7 0.0001
1 Microtubule Inhibitor [EPC] 7 0.0000
2 Topoisomerase Inhibitor [EPC] 3 0.0000
3 Estrogen Receptor Antagonist [EPC] 1 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
5 Platinum-based Drug [EPC] 3 0.0000
6 Kinase Inhibitor [EPC] 6 0.0000
7 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
8 Progestin [EPC] 1 0.0000
See all drug classes enriched for association with NEUROENDOCRINE BREAST TUMOUR